R. Sutherland

Elevated levels of tumour apolipoprotein D independently predict poor outcome in breast cancer patients
202031 citationsauthor #11
Steroidal control of cell proliferation in the breast and breast cancer
20200 citationsauthor #2
2 Antiestrogens and the Cell Cycle
20190 citationsauthor #7
The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease Outcome
201869 citationsauthor #15
Genomic analyses identify molecular subtypes of pancreatic cancer
20163,096 citationsauthor #95
Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells
20141 citationsauthor #3
ZNF300P1 Encodes a lincRNA that regulates cell polarity and is epigenetically silenced in type II epithelial ovarian cancer
20140 citationsauthor #7
ZNF300P1 Encodes a lincRNA that regulates cell polarity and is epigenetically silenced in type II epithelial ovarian cancer
201439 citationsauthor #7
Methylation-capture and Next-Generation Sequencing of free circulating DNA from human plasma
201465 citationsauthor #11
Haematopoietic stem cell induction by somite-derived endothelial cells controlled by meox1
2014131 citationsauthor #12
Direct Crosstalk Between Cancer and Osteoblast Lineage Cells Fuels Metastatic Growth in Bone via Auto‐Amplification of IL‐6 and RANKL Signaling Pathways
201444 citationsauthor #10
Enhanced RAD21 Cohesin Expression Confers Poor Prognosis and Resistance to Chemotherapy in High Grade Luminal, Basal, and HER 2 Breast Cancers
201416 citationsauthor #16
β-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression.
201376 citationsauthor #10
Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells
201329 citationsauthor #3
Global characterization of signalling networks associated with tamoxifen resistance in breast cancer
201343 citationsauthor #18
Sirtuin-1 regulates acinar-to-ductal metaplasia and supports cancer cell viability in pancreatic cancer.
201366 citationsauthor #10
Adjuvant chemotherapy in elderly patients with pancreatic cancer
201367 citationsauthor #21
Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1
201341 citationsauthor #5
A novel method of bladder neck imbrication to improve early urinary continence following robotic-assisted radical prostatectomy
20133 citationsauthor #11
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater.
2013158 citationsauthor #39
ErbB 2-mediated mammary tumor progression
20130 citationsauthor #12
Cancer Cell Viability in Pancreatic Cancer Sirtuin-1 Regulates Acinar-to-Ductal Metaplasia and Supports
20131 citationsauthor #10
Adjuvant chemotherapy in elderly patients with pancreatic cancer
201367 citationsauthor #20
Outcomes of transperineal template‐guided prostate biopsy in 409 patients
201370 citationsauthor #6
Regional activation of the cancer genome by long-range epigenetic remodeling.
2013202 citationsauthor #7
Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer
201396 citationsauthor #16
Transcription factor ATF3 links host adaptive response to breast cancer metastasis.
2013121 citationsauthor #15
Abstract A4: Whole genome sequencing of free circulating DNA from plasma of HGSOC patients
20130 citationsauthor #8
Location and pathological characteristics of cancers in radical prostatectomy specimens identified by transperineal biopsy compared to transrectal biopsy.
2012104 citationsauthor #9
The prognostic and predictive value of serum CA19.9 in pancreatic cancer
2012273 citationsauthor #23
673 Open versus robotic-assisted radical prostatectomy: A comparison of urinary and sexual quality of life outcomes
20120 citationsauthor #10
Inhibitors of cell cycle kinases: recent advances and future prospects as cancer therapeutics.
201259 citationsauthor #2
High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy
201287 citationsauthor #11
RON is not a prognostic marker for resectable pancreatic cancer
20121 citationsauthor #10
34. Prediction of outcome of early luminal breast cancer is improved using a biomarker panel which includes KI-67 and P53
20120 citationsauthor #13
The role of the bone microenvironment in skeletal metastasis
201274 citationsauthor #4
Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer.
2012107 citationsauthor #12
1471 QUALITY OF LIFE OUTCOMES AMONGST MEN UNDERGOING CONTEMPORARY TECHNIQUES FOR THE TREATMENT OF LOCALISED PROSTATE CANCER: A PROSPECTIVE STUDY
20120 citationsauthor #10
35. Hedgehog overexpression is regulated by stromal interactions and predicts for poor outcome in invasive ductal carcinoma
20120 citationsauthor #8
Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX
20127 citationsauthor #13
The prognostic and predictive value of serum CA19.9 in pancreatic cancer
2012273 citationsauthor #24
Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers.
201253 citationsauthor #7
Intrinsic subtype and its clinical significance in early node-negative breast cancer: Results from two randomized trials of adjuvant chemoendocrine therapy.
20120 citationsauthor #15
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
20121,941 citationsauthor #121
1122 Identifying Putative MiRNAs Mediators of Radiotherapy Resistance in Breast Cancer
20120 citationsauthor #6
RON is not a prognostic marker for resectable pancreatic cancer
201218 citationsauthor #10
Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX
201258 citationsauthor #13
Cyclin E2 Overexpression Is Associated with Endocrine Resistance but not Insensitivity to CDK2 Inhibition in Human Breast Cancer Cells
2012141 citationsauthor #13
TCPTP Regulates SFK and STAT3 Signaling and Is Lost in Triple-Negative Breast Cancers
201286 citationsauthor #10
Tamoxifen-Induced Epigenetic Silencing of Oestrogen-Regulated Genes in Anti-Hormone Resistant Breast Cancer
201260 citationsauthor #9
Hedgehog overexpression is associated with stromal interactions and predicts for poor outcome in breast cancer.
2011169 citationsauthor #20
Molecular pathologic phenotypes and outcome in adenocarcinoma of the ampulla of Vater.
20110 citationsauthor #8
Low AZGP1 expression predicts for recurrence in margin‐positive, localized prostate cancer
201144 citationsauthor #8
30. MAL2 and tumour protein D52 (TPD52) overexpression in ovarian carcinoma, association with histological subtype and clinical outcome
20111 citationsauthor #10
Pathways of chemotherapy resistance in castration-resistant prostate cancer.
201194 citationsauthor #3
PP 68 Cytokines' profiles to predict chemotherapy outcome in castration resistant prostate cancer (CRPC)
20110 citationsauthor #9
The expression of the ubiquitin ligase SIAH2 (seven in absentia homolog 2) is mediated through gene copy number in breast cancer and is associated with a basal-like phenotype and p53 expression
201150 citationsauthor #12
Endocrine-Related Cancer ( 2011 ) 18 R 103 – R 123 Pathways of chemotherapy resistance in castration-resistant prostate cancer
20111 citationsauthor #3
LMO4 expression in squamous cell carcinoma of the anterior tongue
201110 citationsauthor #12
Immunohistochemistry of methyl guanine DNA methyltransferase (MGMT) in () normal bronchial epitheliu
20110 citationsauthor #7
42. PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality
20117 citationsauthor #8
Endocrine resistance in breast cancer: new roles for ErbB3 and ErbB4
201127 citationsauthor #1
Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers
2011102 citationsauthor #15
A study of methylated glutathione s-transferase 1 (mGSTP1)as a potential plasma epigenetic marker of response to chemotherapy and prognosis in men with castration-resistant prostate cancer (CRPC).
20113 citationsauthor #11
Recruitment and Activation of Pancreatic Stellate Cells from the Bone Marrow in Pancreatic Cancer: A Model of Tumor-Host Interaction
201158 citationsauthor #10
ANZ1001 SORBET: Study of Oestrogen Receptor Beta and Efficacy of Tamoxifen-A single-arm, phase II study of the efficacy of tamoxifen in triple-negative but estrogen receptor beta-positive metastatic breast cancer.
20112 citationsauthor #10
Abstract 2843: Tumor macrophages utilize ATF3 to promote breast cancer metastasis
20110 citationsauthor #7
Interleukin 6 promotes the growth of breast cancer bone metastasis
20110 citationsauthor #7
Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers
2011162 citationsauthor #10
41. Differences in cell cycle and apoptotic biomarker expression between molecular subtypes of invasive ductal breast carcinoma
20110 citationsauthor #11
ANZ1001 SORBET: Study of Oestrogen Receptor Beta and Efficacy of Tamoxifen--A single-arm, phase II study of the efficacy of tamoxifen in triple-negative but estrogen receptor beta-positive metastatic breast cancer.
20112 citationsauthor #10
Retinoid Signaling in Pancreatic Cancer, Injury and Regeneration
201121 citationsauthor #12
TLE3 Expression Is Associated with Sensitivity to Taxane Treatment in Ovarian Carcinoma
201120 citationsauthor #5
Synthesis and in vitro evaluation of analogues of avocado-produced toxin (+)-(R)-persin in human breast cancer cells.
201116 citationsauthor #5
Preclinical strategies to define predictive biomarkers for therapeutically relevant cancer subtypes
201114 citationsauthor #4
755 poster ENHANCED RAD21 COHESIN EXPRESSION CONFERS POOR PROGNOSIS AND RESISTANCE TO CHEMOTHERAPY IN HIGH GRADE LUMINAL, BASAL AND HER2 BREAST CANCERS
20111 citationsauthor #6
A molecular prognostic nomogram for resectable pancreatic cancer.
20117 citationsauthor #8
151 QUALITY OF LIFE CHANGES FOLLOWING RADICAL PROSTATECTOMY: A PROSPECTIVE COMPARISON OF ROBOTIC & OPEN TECHNIQUES
20110 citationsauthor #11
Cytokines' profiles to predict chemotherapy outcome in castration-resistant prostate cancer (CRPC).
20113 citationsauthor #13
40. Cytoplasmic localisation of β catenin is a marker of poor outcome in breast cancer patients
20110 citationsauthor #7
BAG-1 overexpression attenuates luminal apoptosis in MCF-10A mammary epithelial cells through enhanced RAF-1 activation
201024 citationsauthor #3
Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development
2010151 citationsauthor #15
29. c-MYC gene amplification is associated with a poor prognosis in invasive ductal carcinoma
20103 citationsauthor #7
Cytoplasmic Localization of β-Catenin is a Marker of Poor Outcome in Breast Cancer Patients
2010139 citationsauthor #7
Cancer esearch or and Stem Cell Biology sine Phosphorylation Profiling Reveals the Signaling R work Characteristics of Basal Breast Cancer Cells
20100 citationsauthor #18
PI3K pathway activation in breast cancer is associated with the basal‐like phenotype and cancer‐specific mortality
2010313 citationsauthor #9
Overexpression of the oncogenic signal transducer Gab2 occurs early in breast cancer development
201033 citationsauthor #11
300 CAN THE GLEASON GRADE AT THE SITE OF A POSITIVE MARGIN PREDICT BIOCHEMICAL FAILURE POST RADICAL PROSTATECTOMY
20100 citationsauthor #6
Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers
2010297 citationsauthor #17
BAG-1 overexpression attenuates luminal apoptosis in MCF-10A mammary epithelial cells through enhanced RAF-1 activation
201024 citationsauthor #2
Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells.
2010178 citationsauthor #18
Comparative Biomarker Expression and RNA Integrity in Biospecimens Derived from Radical Retropubic and Robot-Assisted Laparoscopic Prostatectomies
201013 citationsauthor #14
Stage migration in localized prostate cancer has no effect on the post‐radical prostatectomy Kattan nomogram
201014 citationsauthor #6
Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers
201058 citationsauthor #17
Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status
201019 citationsauthor #18
CAN-10-0911 Cancer esearch or and Stem Cell Biology sine Phosphorylation Profiling Reveals the Signaling R work Characteristics of Basal Breast Cancer Cells
20100 citationsauthor #18
Abstract S6-8: Hedgehog Ligand Overexpression Predicts Poor Outcome in Breast Cancer and Is a Potential Therapeutic Target for Metastatic Disease
20101 citationsauthor #10
MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome
201061 citationsauthor #10
High Notch1 protein expression is an early event in breast cancer development and is associated with the HER‐2 molecular subtype
201066 citationsauthor #17
Cell cycle proteins in epithelial cell differentiation: Implications for breast cancer
201085 citationsauthor #2

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT